Molecular and neural roles of sodium-glucose cotransporter 2 inhibitors in alleviating neurocognitive impairment in diabetic mice.
鈉葡萄糖共同轉運蛋白2抑制劑在緩解糖尿病小鼠神經認知障礙中的分子和神經作用。
Psychopharmacology (Berl) 2023-04-27
Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer's Disease.
Canagliflozin,一種鈉葡萄糖共同轉運蛋白2抑製劑,和多奈哌齡聯合治療在阿茲海默症的臨床前研究。
Pharmaceuticals (Basel) 2023-11-27
Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis.
SGLT2抑制劑在糖尿病患者中對失智症發病和認知功能的潛在作用:系統性回顧和荟萃分析。
Front Neuroendocrinol 2024-02-24
Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study.
鈉葡萄糖共同轉運蛋白2抑制劑對2型糖尿病患者認知功能障礙風險的異質性治療效應:一項基於人群的cohort研究。
Alzheimers Dement 2024-07-03
SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system.
SGLT2 抑制劑:通過對神經系統的多方面影響治療認知障礙的新療法。
Transl Neurodegener 2024-08-09
Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.
在40-69歲的2型糖尿病成人中,啟用鈉-葡萄糖共轉運蛋白-2抑制劑與二肽基肽酶-4抑制劑後癡呆風險的比較:基於人群的隊列研究。
BMJ 2024-08-28
Effects of SGLT2-Inhibitors on Comprehensive Geriatric Assessment, Biomarkers of Oxidative Stress, and Platelet Activation in Elderly Diabetic Patients with Heart Failure with Preserved Ejection Fraction.
SGLT2 抑制劑對心臟功能保留的老年糖尿病患者的綜合老年評估、氧化壓力生物標記及血小板活化的影響。
Int J Mol Sci 2024-08-29
Association of sodium-glucose cotransporter 2 inhibitors with risk of incident dementia and all-cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks.
鈉-葡萄糖共轉運蛋白 2 抑制劑與 2 型糖尿病老年患者新發癡呆風險及全因死亡率的關聯:基於 TriNetX 美國合作網絡的回顧性隊列研究。
Diabetes Obes Metab 2024-09-09